1-(Arylsulfonyl)-4-(Piperazin-1-yl)-1HBenzimidazoles as 5-Hydroxytryptamine-6 Ligands

Details for Australian Patent Application No. 2009314221 (hide)

Owner Wyeth LLC

Inventors Haydar, Simon N.; Andrae, Patrick M.; Yun, Heedong; Robichaud, Albert J.

Agent Allens Patent & Trade Mark Attorneys

Pub. Number AU-B-2009314221

PCT Pub. Number WO2010/056644

Priority 61/113,296 11.11.08 US

Filing date 10 November 2009

Wipo publication date 20 May 2010

Acceptance publication date 30 August 2012

International Classifications

C07D 235/22 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

A61K 31/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 25/00 Drugs for disorders of the nervous system

C07D 403/04 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 487/08 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/056644 Priority application(s): WO2010/056644

30 August 2012 Application Accepted

  Published as AU-B-2009314221

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009314226-A process for removing barium from water

2009314212-Optical machine-readable data representation image